| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_20bde8b86a338e02a61acba66b15acf8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate |
2004-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99098b272e13ebace230e8657b5f1802 |
| publicationDate |
2004-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004078178-A1 |
| titleOfInvention |
Buprenorphine compounds for treatment of alcohol dependence and excessive alcohol use |
| abstract |
The invention relates to use of a buprenorphine compound or a pharmaceutical ac-ceptable salt or ester thereof for the preparation of a pharmaceutical composition for preventing or treating alcohol dependence and excessive alcohol use. It also concerns the use of a buprenorphine compound together with an opiate receptor antagonist and a method for treating or preventing of alcohol dependence and excessive alcohol use. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9051334-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7511054-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9259422-B2 |
| priorityDate |
2003-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |